Lipopolysaccharide-binding protein, a surrogate marker of microbial translocation, is associated with physical

John R Stehle1, Xiaoyan Leng, Dalane W Kitzman

  • 1Section on Gerontology and Geriatric Medicine, Department of Internal Medicine, Wake Forest School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157, USA. jstehle@wakehealth.edu

Abstract

Insights

In healthy older adults, lipopolysaccharide binding protein (LBP), a marker of microbial translocation, is linked to reduced physical function and increased inflammation. Further research is needed to clarify this relationship.

Area of Science:

  • Gerontology
  • Immunology
  • Microbiology

Background:

  • Physical function naturally declines with age, accompanied by increased inflammation.
  • Microbial translocation (MT) involves systemic exposure to microbes without overt bacteremia.
  • MT markers like soluble CD14 (sCD14) and lipopolysaccharide binding protein (LBP) may drive chronic inflammation in aging.

Purpose of the Study:

  • To investigate the association between MT biomarkers (sCD14, LBP) and physical function in healthy older adults.
  • To explore the relationship between MT biomarkers and inflammatory markers.

Main Methods:

  • Cross-sectional study of 59 healthy older adults (60-89 years).
  • Assessed plasma biomarkers of MT (sCD14, LBP), physical function (grip strength, SPPB, gait speed, etc.), and inflammation (CRP, IL-6, TNF-α).

Main Results:

  • LBP was inversely correlated with SPPB score and grip strength, and positively correlated with CRP.
  • sCD14 showed correlations with IL-6, TNF-α, and TNFsR1.
  • The association between LBP and physical function remained significant after adjusting for inflammatory biomarkers.

Conclusions:

  • In healthy older individuals, LBP, a surrogate marker of MT, is associated with poorer physical function and inflammation.
  • Further investigation is required to determine if MT causes or is merely a marker of inflammation and functional decline.

Related Concept Videos

Formation of Lipopolysaccharides01:19

Formation of Lipopolysaccharides

Lipopolysaccharides (LPS) are crucial components of the outer membrane of Gram-negative bacteria, serving both structural and functional roles. It contributes to membrane stability and protects bacteria from host immune responses. LPS is composed of three major regions—lipid A, a core oligosaccharide, and an O antigen. The biosynthesis and assembly of LPS involve a highly coordinated set of enzymatic reactions and transport mechanisms. Additionally, LPS is recognized as an endotoxin, triggering...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
Factors Affecting Protein-Drug Binding: Patient-Related Factors01:29

Factors Affecting Protein-Drug Binding: Patient-Related Factors

Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...